BIOLOGÍA MOLECULAR Y CELULAR EN HEMOPATÍAS
Louisiana State University Health Sciences Center New Orleans
Nueva Orleans, Estados UnidosPublicacións en colaboración con investigadores/as de Louisiana State University Health Sciences Center New Orleans (1)
2014
-
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
British Journal of Haematology, Vol. 167, Núm. 4, pp. 466-477